课题基金 / 基金详情

The role of anti-retroviral therapy in the increased rate of COVID-19 mortality of people living with HIV

The role of anti-retroviral therapy in the increased rate of COVID-19 mortality of people living with HIV
抗逆转录病毒治疗在艾滋病毒感染者 COVID-19 死亡率增加中的作用
批准号：
459251
负责人：
Schurr Erwin A
金额：
$36.43万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=459251&lang=en
关键词：
Hiv And Sars-Cov-2

项目摘要

项目成果

Schurr Erwin A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent large cohort studies have identified HIV infection as strong risk factor for severe COVID- 19. Importantly, even PLWH with low or undetectable HIV load and reconstituted CD4+ T-cell immunity still display a two-fold increased COVID-19 associated mo
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic factors affecting the anti-mycobacterial immune response of people living with HIV
From Molecules to Patients to Policies Symposium
Host genetic dissection of mycobacterial infection phenotypes
The genetic determinants of human anti-mycobacterial immune reactivity
海外基金